行情

MYOS

MYOS

MYOS RENS
NASDAQ

实时行情|Nasdaq Last Sale

1.380
-0.010
-0.72%
已收盘, 16:00 12/09 EST
开盘
1.490
昨收
1.390
最高
1.490
最低
1.380
成交量
4,474
成交额
--
52周最高
2.020
52周最低
1.070
市值
1,266.41万
市盈率(TTM)
-3.7860
分时
5日
1月
3月
1年
5年

EPS

MYOS 新闻

  • 美农场破产量飙升24%创6年新高 农业危机“在路上”?
  • 第一财经.6天前
  • 资金流向复盘 | 南下资金今日净流入港股超28亿港元
  • 华盛通.6天前
  • 瑞银:欧央行利率会议中性看待欧元 明年有望徐徐上涨
  • 新浪财经综合.6天前
  • 巴西“黑五”电商收入32亿雷亚尔 285万人“剁手”
  • 中国新闻网.6天前

更多

所属板块

食品加工
+0.11%
食品和烟类
+0.25%

热门股票

名称
价格
涨跌幅

MYOS 简况

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
展开

Webull提供MYOS RENS Technology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。